Who are Sedatives/Hypnotics,Other's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Randomization of Propofol or Dexmedetomidine, sedative mixture, I.V Sedation, Intravenous Sedation, Oral Sedatives with or Without Analgesia.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sedatives-hypnotics-other.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Sedatives/Hypnotics,Other — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sedatives/Hypnotics,Other (Sedatives/Hypnotics,Other) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sedative/Hypnotic. Area: Neurology/Psychiatry.

marketed Sedative/Hypnotic Neurology/Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Sedatives/Hypnotics,Other (Sedatives/Hypnotics,Other) — University of Oulu. Sedatives/hypnotics work by enhancing inhibitory neurotransmission in the central nervous system to promote sleep and reduce anxiety.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Sedatives/Hypnotics,Other TARGET	Sedatives/Hypnotics,Other	University of Oulu	marketed	Sedative/Hypnotic
Randomization of Propofol or Dexmedetomidine	Randomization of Propofol or Dexmedetomidine	Children's Hospital Los Angeles	marketed	Sedative/Hypnotic agents	GABA-A receptor (propofol); Alpha-2 adrenergic receptor (dexmedetomidine)
sedative mixture	sedative mixture	Helsinki University Central Hospital	marketed	Sedative/Hypnotic combination
I.V Sedation	I.V Sedation	Nantes University Hospital	marketed	Sedative/hypnotic agent (class varies by specific agent used)
Intravenous Sedation	Intravenous Sedation	Moscow Regional Research and Clinical Institute (MONIKI)	marketed	Sedative/Hypnotic (class varies by specific agent used)
Oral Sedatives with or Without Analgesia	Oral Sedatives with or Without Analgesia	Rocky Vista University, LLC	marketed	CNS depressant (sedative/hypnotic ± analgesic)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sedative/Hypnotic class)

University of Oulu · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sedatives/Hypnotics,Other — Competitive Intelligence Brief. https://druglandscape.com/ci/sedatives-hypnotics-other. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing